Bismuth-containing composition
    4.
    发明公开
    Bismuth-containing composition 失效
    WismuthaltigesArzneipräparat。

    公开(公告)号:EP0380950A2

    公开(公告)日:1990-08-08

    申请号:EP90100737.7

    申请日:1990-01-15

    发明人: Furlan, Diego

    IPC分类号: A61K31/29 A61K9/14 A61K33/24

    摘要: A bismuth-containing product in the form of a powder easily dispersable in water to form a colloidal solution suitable for oral administration as an antiulcer drug is obtained from an aqueous solution of potassium citrate, bismuth citrate and potassium hydroxide, the product being precipitated from the aqueous solution by dilution with acetone.

    摘要翻译: 从柠檬酸钾,柠檬酸铋和氢氧化钾的水溶液中获得容易分散在水中以形成适合作为抗溃疡药物口服给药的胶体溶液形式的含铋产品,产物从 水溶液用丙酮稀释。

    Water-soluble salts of (+)2-(4-fluorophenyl)-alpha-methyl-5-benzoxazole acetic acid and their preparation process
    10.
    发明公开
    Water-soluble salts of (+)2-(4-fluorophenyl)-alpha-methyl-5-benzoxazole acetic acid and their preparation process 失效
    WasserlöslicheSalze der(+)2-(4-氟苯基)-α-甲基-5-苯并恶唑并硫醚和Herstellung。

    公开(公告)号:EP0324402A1

    公开(公告)日:1989-07-19

    申请号:EP89100245.3

    申请日:1989-01-09

    发明人: Furlan, Diego

    摘要: Water-soluble salts of (+)2-(4-fluorophenyl)-alpha-methyl-5-­benzoxazole acetic acid with DL-lysine, D-lysine or L-lysine, suita­ble for the preparation of medicinal specialities such as syrups, creams, suppositories, aqueous solutions for personal hygiene etc, and their preparation process.
    Said salts are obtained by suspending said acid in an organic solvent soluble or partly soluble in water, adding an equivalent quatity of said lysine and crystallizing the salt obtained.

    摘要翻译: (+)2-(4-氟苯基)-α-甲基-5-苯并恶唑乙酸与DL-赖氨酸,D-赖氨酸或L-赖氨酸的水溶性盐,适用于制备药用特性例如糖浆,霜剂 栓剂,个人卫生用水溶液等及其制备方法。 所述盐通过将所述酸悬浮在可溶或部分可溶于水的有机溶剂中,加入所述赖氨酸的等同物质并使所得盐结晶。